Home » Topics » BioWorld Science

BioWorld Science
RSS

NIH contemplates licensing ophthalmic technology to GenVec

Jan. 7, 1998

Cell Genesys to receive milestone payment from HMR for GA-EPO

Jan. 7, 1998

Antitussive properties of Chinoin xanthine explored

Jan. 7, 1998

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

PLC Systems submits requested data related to Heart Laser PMA

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

Drug discovery collaboration established by Aurora and Merck

Jan. 7, 1998

Bristol-Myers Squibb prepares melatonergic agents

Jan. 7, 1998

SKB reports prodrugs of 5-HT2C receptor antagonists

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...